Hepatobiliary MR contrast agents are useful to diagnose hepatocellular carcinoma in patients with Budd-Chiari syndrome

Hepatobiliary MR contrast agents are useful to diagnose hepatocellular carcinoma in patients with Budd-Chiari syndrome

Background & Aims: Hepatobiliary phase (HBP) images can discriminate between benign and malignant liver lesions, but it is unclear if this approach can be used in patients with Budd-Chiari syndrome (BCS). Thus, we aimed to assess the diagnostic utility of HBP images in patients with BCS. Met...

Full description

Bibliographic Details
Main Authors: Morgane Van Wettere, Luisa Paulatto, Lucas Raynaud, Onorina Bruno, Audrey Payancé, Aurélie Plessier, Pierre-Emmanuel Rautou, Valérie Paradis, Dominique Cazals-Hatem, Dominique Valla, Valérie Vilgrain, Maxime Ronot
Format: Article
Language:English
Published: Elsevier 2020-06-01
Series:JHEP Reports
Subjects:
Imaging
non-invasive
vascular liver disease
liver cancer
HCC
tumor
Online Access:http://www.sciencedirect.com/science/article/pii/S2589555920300318

Internet

http://www.sciencedirect.com/science/article/pii/S2589555920300318

Similar Items